Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard J Benjamin

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
Transfusion|October 15, 2016
Amotosalen and ultraviolet-A treated platelets and plasma are safe and efficacious in active hemorrhageRichard J Benjamin, Kent L Carter, Laurence Corash
Transfusion|April 5, 2020
INTERCEPT pathogen-reduced platelets are not associated with higher rates of alloimmunization with (or without) clinical refractoriness in published studiesRichard J Benjamin, Laurence Corash, Philip J Norris
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|March 15, 2022
Is pathogen reduction an acceptable alternative to irradiation for risk mitigation of transfusion-associated graft versus host disease?Marissa Li, Johannes Irsch, Laurence Corash, et al.
The New England Journal of Medicine|August 27, 2015
The Safety of the Blood Supply--Time to Raise the BarEdward L Snyder, Susan L Stramer, Richard J Benjamin
Transfusion|April 25, 2026
Safety and tolerability of amustaline/glutathione pathogen-reduced red blood cells in neonatal ratsAnne North, Laurence Corash, Richard J Benjamin, et al.
Transfusion|April 6, 2019
The argument(s) for lowering the US minimum required content of apheresis platelet componentsRichard J Benjamin, Lou Katz, Richard Gammon, et al.
The New England Journal of Medicine|April 23, 2015
The safety of the blood supply--time to raise the barEdward L Snyder, Susan L Stramer, Richard J Benjamin
Transfusion|August 26, 2017
Hemovigilance monitoring of platelet septic reactions with effective bacterial protection systemsRichard J Benjamin, Thomas Braschler, Tina Weingand, et al.
Transfusion|September 24, 2010
Skin disinfection with a single-step 2% chlorhexidine swab is more effective than a two-step povidone-iodine method in preventing bacterial contamination of apheresis plateletsRichard J Benjamin, Beth Dy, Ryan Warren, et al.
Transfusion|November 22, 2018
The argument(s) for lowering the US minimum required content of apheresis platelet componentsRichard J Benjamin, Louis Katz, Richard R Gammon, et al.
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
Transfusion|October 15, 2016
Amotosalen and ultraviolet-A treated platelets and plasma are safe and efficacious in active hemorrhageRichard J Benjamin, Kent L Carter, Laurence Corash
Transfusion|April 5, 2020
INTERCEPT pathogen-reduced platelets are not associated with higher rates of alloimmunization with (or without) clinical refractoriness in published studiesRichard J Benjamin, Laurence Corash, Philip J Norris
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|March 15, 2022
Is pathogen reduction an acceptable alternative to irradiation for risk mitigation of transfusion-associated graft versus host disease?Marissa Li, Johannes Irsch, Laurence Corash, et al.
The New England Journal of Medicine|August 27, 2015
The Safety of the Blood Supply--Time to Raise the BarEdward L Snyder, Susan L Stramer, Richard J Benjamin
Transfusion|April 25, 2026
Safety and tolerability of amustaline/glutathione pathogen-reduced red blood cells in neonatal ratsAnne North, Laurence Corash, Richard J Benjamin, et al.
Transfusion|April 6, 2019
The argument(s) for lowering the US minimum required content of apheresis platelet componentsRichard J Benjamin, Lou Katz, Richard Gammon, et al.
The New England Journal of Medicine|April 23, 2015
The safety of the blood supply--time to raise the barEdward L Snyder, Susan L Stramer, Richard J Benjamin
Transfusion|August 26, 2017
Hemovigilance monitoring of platelet septic reactions with effective bacterial protection systemsRichard J Benjamin, Thomas Braschler, Tina Weingand, et al.
Transfusion|September 24, 2010
Skin disinfection with a single-step 2% chlorhexidine swab is more effective than a two-step povidone-iodine method in preventing bacterial contamination of apheresis plateletsRichard J Benjamin, Beth Dy, Ryan Warren, et al.
Transfusion|November 22, 2018
The argument(s) for lowering the US minimum required content of apheresis platelet componentsRichard J Benjamin, Louis Katz, Richard R Gammon, et al.
Pageof 9